Aiming for protective T-cell responses: a focus on the first generation conserved-region HIVconsv vaccines in preventive and therapeutic clinical trials

T Hanke - Expert Review of Vaccines, 2019 - Taylor & Francis
Introduction: Despite life-saving antiretroviral drugs, an effective HIV-1 vaccine is the best
solution and likely a necessary component of any strategy for halting the AIDS epidemic …

Aiming for protective T-cell responses: a focus on the first generation conserved-region HIVconsv vaccines in preventive and therapeutic clinical trials

T Hanke - Expert review of vaccines, 2019 - pubmed.ncbi.nlm.nih.gov
Introduction: Despite life-saving antiretroviral drugs, an effective HIV-1 vaccine is the best
solution and likely a necessary component of any strategy for halting the AIDS epidemic …

[PDF][PDF] Aiming for protective T-cell responses: a focus on the first generation conserved-region HIVconsv vaccines in preventive and therapeutic clinical trials

T Hanke - Expert Review of Vaccines, 2019 - scholar.archive.org
Introduction: Despite life-saving antiretroviral drugs, an effective HIV-1 vaccine is the best
solution and likely a necessary component of any strategy for halting the AIDS epidemic …

[PDF][PDF] Aiming for protective T-cell responses: A focus on the first generation conserved-region HIVconsv vaccines in preventive and therapeutic clinical trials

T Hanke - Expert Review of Vaccines, 2019 - ora.ox.ac.uk
Introduction: Despite life-saving antiretroviral drugs, an effective HIV-1 vaccine is the best
solution and likely a necessary component of any strategy for halting the AIDS epidemic …

Aiming for protective T-cell responses: a focus on the first generation conserved-region HIVconsv vaccines in preventive and therapeutic clinical trials.

T Hanke - Expert Review of Vaccines, 2019 - europepmc.org
Introduction: Despite life-saving antiretroviral drugs, an effective HIV-1 vaccine is the best
solution and likely a necessary component of any strategy for halting the AIDS epidemic …